ABAbida Bhat

Abida Bhat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abida Bhat has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Epigenetic modulation of VEGF-A/VEGFR2 pathway genes in OC/TME axis driving genetic upregulation and tumor plasticity

    by Abida Bhat, Yasir Bashir, Abdul Basit Baba, Sadaf Dar, Sheikh Zahoor Ahmad, Syed Besina Yasin, Ab Wahid Mir, Syed Nisar Ahmad, Tahira Yousuf, Dil Afroze

    Tumor heterogeneity has been recognized as a critical characteristic of Ovarian Cancer (OC), significantly influencing chemotherapeutic response and overall patient survival. The VEGF/VEGFR2 signaling pathway genes serve as risk factor for metastasis and are associated with poor prognosis in many cancers including OC. DNA methylation of VEGF-A, VEGF-C and VEGFR2 genes contributing to their genetic changes based on histological sub-types has not been thoroughly explored in OC. Thus, the study aimed to determine the DNA methylation status of these genes in relation to their expression in tumor tissues and associated peritoneal fluid samples to evaluate usefulness of methylation as a prognostic indicator in ovarian carcinoma for future targeted therapies. Bisulfite-modified DNA methylation was assessed via Methylation-Specific Polymerase chain reaction (MSP) and mRNA expression was examined via quantitative reverse transcription PCR (RT-PCR), respectively. Gene expression and promoter methylation were examined in relation with clinical parameters in 100 OC samples. The methylation frequency of VEGF-A, VEGF-C and VEGFR2 promoters was higher in tumor tissues and matched Peritoneal Fluid (PF) compared to normal samples, while VEGF-A, VEGF-C and VEGFR2 mRNA expression levels were significantly elevated. Promoter methylation levels for VEGF-A (82%), VEGF-C (76%) and VEGFR2 (82%) showed significantly higher levels compared to benign cystadenomas, whereas amounts of VEGF-A and VEGFR2 were significantly higher than benign samples (p = 0.0003 and 0.001). Expression and promoter methylation for VEGF-A (p = 0.0004, 0.0001) and VEGFR2 (p = 0.005, 0.001) significantly correlated with differences in histological sub-types in OC samples. No significant correlation was observed between promoter methylation and expression levels for VEGF-A, VEGF-C and VEGFR2 genes. Kaplan-Meier survival analysis predicts poor prognosis for concurrent high expression and methylation of VEGF-A and VEGFR2 significantly correlated with advanced stage (log-rank p = 0.03, 0.01) and tumor histology (log rank p = 0.02, 0.01 respectively) in OC patients. Promoter methylation status of the VEGF-A and VEGFR2 genes could serve as valuable prognostic indicator in predicting poor prognosis in OC patients based on tumor histological sub-types.


  • Atis (Annona squamosa)

    by Bharti Mittu, Zerina Begum, Sandaldeep Kaur, Mahaldeep Kaur, Abida Bhat, Neha Sharma, Raees Ul Haq

    Annona squamosa grows in both tropical and subtropical regions. Commonly known as ‘Atis’, it is known to have, in addition to its nutritional significance, a range of pharmacological applications. The fruits of the plant are used a delicacy, and traditionally it has also been used for the treatment of different diseases and disorders. It can be employed in a number of applications, drawing on its analgesic, antitumor and anti-inflammatory properties. The antimalarial, antioxidant and insecticidal activities of the plant have also been reported, in addition to anti-ulcerative properties. In recent times, the bioactive profile of the plant has received considerable significant attention due to the presence of promising bioactive compounds, including acetogenins, fatty acids, alkaloids, quinones flavonoids, terpenoids, saponins, glycosides, tannins, diterpenes, sesquiterpenes, anthocyanins, steroids, etc.

  • Genetically engineered potato

    by Bharti Mittu, Mahaldeep Kaur, Abida Bhat, Jasmeet Kour, Kawaljeet Kour

    With an expanding population, demand for food availability has increased at an alarming rate. Global food security is characterized as food stability, food productivity, cultivable quality, resources requirements, and accessibility of food. These demands have led to the utilization of new genetically modified (GM) breeding techniques for crops with sustainable growth, cultivation productivity, and nutrition sufficiency. Genetic modification generates new breeding lines with high resistance to diseases and the incorporation of desired agronomic traits. In this chapter we discuss the scientific aspects of genetically engineered potato, new breeding technologies (NBTs) for generating the transgenic potato with the desired agronomic traits, and its impact on the global agriculture industry and the social and ethical issues associated with it.